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Abstract 
Background: Glycoproteins play a critical role in the cellular activities of eukaryotes. Sialic acid is typically the outer-
most monosaccharide of glycolipids and glycoproteins, and is necessary for normal development.
Results: A strategy based on avidin–biotin affinity was established to enrich sialylated glycoproteins from HeLa 
cervical carcinoma, SW1990 pancreatic adenocarcinoma, and A549 lung adenocarcinoma cells. Using HPLC–MS/MS, 
western blot, real-time PCR, and enzyme-linked immunosorbent assay, gp96 was identified in all three cell lines. No 
significant difference in the protein expression of gp96 was detected at the whole cell level, but the amount of bioti-
nylated gp96 in SW1990 cells was 30–40 % lower than that in A549 and HeLa cells, and the amount of sialylated gp96 
in SW1990 cells was 30 % lower than that in A549 and HeLa cells. Immunoblotting results showed that the expression 
of sialyltransferase proteins in the total cell lysates from HeLa and A549 cells were higher than that in SW1990 cells.
Conclusions: We established a new method for investigating the expression and sialylation of glycoproteins using 
metabolic labeling, click chemistry, and avidin–biotin affinity. We successfully used this method to purify sialylated 
glycoproteins from cancer cell lines. Our results showed that the levels of gp96 sialylation varied across different can-
cer cell lines, and this may be because of differences in sialyltransferase expression.
Keywords: Click chemistry, Sialic acid, gp96, Sialyltransferase
© 2015 Liang et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Glycosylation is an important post-translational modifi-
cation of eukaryotic proteins [1]. This modification plays 
crucial roles in various biological events, such as cell rec-
ognition, inter- and intracellular signaling, cell adhesion, 
and cell–cell interactions [2]. Different levels of glycosyla-
tion are often observed in pathological cells compared 
with normal cells and are regarded as a hallmark of dis-
ease states [3]. For example, cancer cells frequently dis-
play glycans at different levels or with fundamentally 
different structures than those observed on normal cells 
[3]. Sialic acid is typically the outermost monosaccharide 
unit on the glycan chains of glycolipids and glycopro-
teins, and is often part of the recognition sites to which 
pathogens attach [4]. Sialic acid not only provides impor-
tant intrinsic functions but also is necessary for normal 
development. The functional significance of changes in 
the amount of sialic acid in disease-associated states has 
been reported, and abnormal changes in the amount of 
sialic acid were observed in prostate, colon, and stomach 
cancers, among others [4, 5].
Click chemistry is the most practical and reliable 
set of chemical reactions to connect a diverse range of 
structures. The Cu(I)-catalyzed azide-alkyne 1,3-dipo-
lar cycloaddition is one of the most common reactions 
in click chemistry and demonstrates high yield, good 
efficiency, and high purity [6]. This click reaction also 
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demonstrates excellent selectivity in chemical synthe-
sis [7]. Because the azide and alkyne groups are easily 
introduced into the structure of molecules, this reac-
tion has been widely used for the fabrication of bio-
logical or chemical sensors. For example, the unnatural 
sugar N-a-azidoacetylmannosamine (ManNAz) was 
metabolized by cultured cells to N-a-azidoacetyl sialic 
acid (SiaNAz) and incorporated into membrane gly-
coconjugates. Azido-labeled glycoproteins were then 
reacted with the alkyne probe using click chemis-
try, and optical imaging indicated a significant azido-
labeled N-acetylmannosamine-dependent increase on 
the cell surface [8, 9].
In this study, mannose was modified with an azide 
group, metabolized by cells, and presented on glyco-
proteins. Azido-labeled glycoproteins were biotinylated 
using a Cu(I)-catalyzed [3  +  2] cycloaddition reaction 
with an alkyne probe. Additionally, a strategy for isolat-
ing cell-surface sialylated glycoproteins based on avi-
din–biotin affinity was established. We used this strategy 




HeLa, SW1990, and A549 cells were cultured for 48  h 
with 0.2 mM Ac4ManNAz to allow the cultured cells to 
metabolize and incorporate the synthetic Ac4ManNAz 
into membrane glycoproteins. The azides present on the 
glycoproteins reacted with the biotin-LC-alkyne probe, 
generating the biotinylated glycoproteins through click 
chemistry. Cells were stained using avidin-Cy3, and at 
a 570-nm excitation wavelength, a clear fluorescence 
signal was observed on the cell surfaces (Fig.  1), which 
indicated that the cells had metabolized Ac4ManNAz. 
No fluorescence was observed in the control cells. These 
results suggested that the increased fluorescence resulted 
from a specific affinity for azido glycans and that the 
azido groups on the cell surface might undergo a highly 
selective reaction with the biotin-LC-alkyne probe. Addi-
tionally, we did not observe fluorescence within the cells, 
which indicated that the biotin-LC-alkyne probe cannot 
penetrate the cell membrane and that the biotinylation 
only occurred on the cell surface of the surviving cells 
through click chemistry.
Fig. 1 Fluorescent labeling of azido groups on the cell surface
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Isolation of the biotinylated glycoproteins
After isolation of the glycoproteins present on the cell 
surface using the biotin- avidin system, the amount of 
obtained glycoproteins was analyzed using Coomas-
sie Brilliant Blue G-250 staining, and the level of 
biotinylation was examined. Coomassie staining of 
the total cell lysates revealed mostly similar protein 
bands between the labeled and control cells, with only 
minor differences (Fig.  2a), which suggested that the 
unnatural sugar did not affect cellular metabolism. In 
contrast, HRP-streptavidin detected extensive bioti-
nylation of proteins in the labeled cells. Figure  2b 
demonstrates an equal molecular weight distribu-
tion. This result suggested that the azido groups were 
effectively metabolized and specifically biotinylated. 
SDS-PAGE analysis of the purified proteins that were 
isolated using streptavidin magnetic microspheres 
(SMMs) indicated many specific protein bands in the 
labeled cells compared with the control cells (Fig. 2c). 
Additionally, the azido-labeled proteins could be spe-
cifically biotinylated in contrast to the control cells 
(Fig.  2d). Collectively, these results indicated that the 
metabolized synthetic sugar was incorporated into 
glycoproteins and it could be specifically biotinylated 
and detected. Furthermore, the corresponding glyco-
proteins could be isolated using SMMs for subsequent 
analysis.
The expression of gp96 in different cancer cell lines
The glycoproteins were isolated from labeled HeLa, 
A549, and SW1990 cells and analyzed using HPLC–MS/
MS. The results identified the gp96 heat shock protein 
in each cell line (Fig. 3). Real-time PCR and western blot 
analysis confirmed these results. Real-time PCR revealed 
that the expression of gp96 mRNA was 30  % higher in 
HeLa cells than that in A549 and SW1990 cells, using 
GAPDH as an internal control (Fig. 4a), However, west-
ern blot analysis indicated no significant difference in 
gp96 protein expression in all three cell lines (Fig.  4b). 
One possible explanation may be that efficiency or reg-
ulation of translation may have affected the level of the 
expressed protein. Despite the discrepancy in the two 
results, the western blot results provide the actual levels 
of expressed cellular protein. Simultaneously, the varia-
tions were observed in the western blot for biotinylated 
gp96 (Fig. 4b).
Variations in sialylation of gp96 in different cancer cell 
lines
The amount of gp96 in the purified glycoprotein sam-
ple was detected using western blot analysis. As shown 
in Fig. 4b, the amount of purified gp96 protein by SMMs 
was clearly lower in SW1990 cells than in HeLa and 
A549 cells. Additionally, enzyme-linked immunosorb-
ent assay (ELISA) was used to measure the level of gp96 
Fig. 2 Purification of glycoproteins. a Coomassie Brilliant Blue staining of the total cell lysate. b Western blot analysis of the total cell lysate using 
HRP-streptavidin. c Coomassie Brilliant Blue staining of the purified proteins. d Western blot analysis of the purified proteins using HRP-streptavidin. 
Con control, Az Ac4ManNAz
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Fig. 3 Identification of gp96 using HPLC–MS/MS. MS/MS spectra indicating peptide sequences of gp96 that were detected in a HeLa, b A549, and 
c SW1990 cells
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biotinylation in the different cell lines. We observed that 
the level of biotinylated gp96 in SW1990 cells was only 
71 and 64 % of that in HeLa and A549 cells, respectively 
(P < 0.05) (Fig. 4c). The lower level of biotinylated gp96 in 
SW1990 cells resulted in a lower amount of gp96 in the 
purified glycoprotein sample. Differences in the morphol-
ogy of adherent cells and growth rates of the different cell 
lines precluded the evaluation of gp96 expression on the 
cell surface. Therefore, ELISA was used to determine the 
sialylation level of gp96 in the different cancer cell lines 
using HRP-WGA. As shown in Fig.  4d, the level of sia-
lylated gp96 in SW1990 was 79  % of that in A549 and 
HeLa cells (P < 0.01), which suggested that the sialylation 
level of gp96 differs in different cancer cell lines and indi-
cated that the sialylation level of gp96 or perhaps other 
glycoproteins may play an important role in tumorigen-
esis and development.
Expression of sialyltransferase in different cancer cell lines
To investigate the observed differences in sialyla-
tion among the cell lines, we performed western blot 
analysis on the same concentration of total proteins 
from the three cell lines to analyze the expression of 
glycosyltransferases related to sialylation, includ-
ing alpha-2,3-sialyltransferase (ST3Gal) and alpha-
2,6-sialystransferase 1 (ST6Gal1). As shown in Fig. 5, 
Fig. 4 Expression, biotinylation, and sialylation of gp96 in different cancer cell lines. a The expression of gp96 mRNA in different cancer cell lines 
was determined using real-time PCR and normalized to GADPH expression. b The expression of gp96 protein and amount of biotinylated gp96 
obtained after purification from different cancer cell lines were determined using western blot analysis. β-actin served as an internal control. c The 
variation in the degree of biotinylation of gp96 was determined using ELISA. d The variation in the degree of sialylation of gp96 was determined 
using ELISA
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the expression of ST3Gal and ST6Gal1 in the total 
cell lysates from Hela and A549 cells were obviously 
higher than in SW1990 cells, which reflected the simi-
lar trend in sialylation level of gp96 in the three cell 
lines. These results indicated that the difference of 
sialyltransferase may be one important reason result-
ing in the variations in sialylation of gp96 in different 
cell lines.
Levels of sialylated gp96 in two breast cancer cell lines
To investigate specifically reference differences in metas-
tasis capability between the cell lines, the sialylation of 
gp96 was analyzed in MCF-7 and SK-BR-3 cell lines, both 
from breast cancer tissues. As shown in Fig.  6, ELISA 
results revealed that levels of sialylated gp96 in SK-BR-3 
cells were higher than in MCF-7 cells, which was con-
sistent with metastasis capability. These results indi-
cated that the difference of sialylated levels may affect the 
metastasis potential of tumor cells.
Discussion
Glycoproteins play very important roles in cellular 
activities. Currently, several methods for isolating glyco-
proteins are widely used, including lectin affinity chro-
matography, and hydrazide chemistry, among others. 
Lectins have been chosen for the enrichment and visu-
alization of glycoproteins for decades, and lectin-based 
capture of glycopeptides and glycoproteins has become 
a desirable method for glycoproteomic analysis [10]. 
The hydrazide capture method involves the initial oxida-
tion of sugar residues in the glycosylated peptides using 
periodate before reaction with a hydrazide resin [11]. 
Click chemistry offers a novel method to label glycopro-
teins. Using specifically modified sugars, click chemistry 
enables a more specific isolation of labeled glycoproteins 
than lectin-based capture methods. In our study, man-
nose was modified with an azide group, metabolized by 
cells and incorporated instead of the natural sugars into 
glycoproteins that were presented on the cell surface. 
The resulting sialylated glycoproteins present on the cell 
surface were subsequently isolated and purified. Our 
strategy offers a new method for investigating the expres-
sion and sialylation of glycoproteins and a new tool for 
glycoproteomics.
Our strategy for isolating cell-surface sialylated glyco-
proteins was applied to three different cancer cell lines: 
A549 lung adenocarcinoma, HeLa cervical carcinoma, 
and SW1990 pancreatic adenocarcinoma cells. Glyco-
protein fractions were then analyzed using HPLC–MS/
MS and the results identified the gp96 protein in the gly-
coprotein fraction of all three cell lines. The endoplas-
mic reticulum-resident chaperone protein gp96 belongs 
to a class of conserved molecular chaperones known as 
heat shock proteins and is a member of the HSP90 fam-
ily. Gp96 is nonpolymorphic and abundant, and it plays 
important roles in the secretory pathway in maintaining 
protein homeostasis [12]. Enzyme-linked immunosorb-
ent assay (ELISA) measured the levels of biotinylation 
and sialylation of gp96 in the different cell lines, and 
revealed variations in the extent of sialylation of gp96 
in different cancer cell lines. These results may suggest 
different immunological and pathological properties of 
gp96 in pancreatic adenocarcinoma cells. Although a 
clear difference was observed, further study is necessary 
to confirm these results and elucidate the mechanism for 
the difference in sialylation; for example, several types 
of glycosyltransferases are related to sialylation, and the 
expression of glycosyltransferases in cells and their cor-
responding activities could affect the degree of sialylation 
[13–17].
Gp96 is found on the surfaces of malignant cells and 
possesses sialylated N-glycans [18]. With the nega-
tive charge on the surface of the glycan imparted by the 
Fig. 5 Expression analysis of sialyltransferase. Western blot analysis 
of sialyltransferase expression in different cancer cell lines was 
performed using anti-ST3Gal antibody and anti-ST6Gal1 antibody. SW 
SW1990 cells, H Hela cells, A A549 cells
Fig. 6 Variations in sialylation of gp96 between MCF-7 and SK-BR-3 
cells
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presence of sialic acid residues, sialic acid is a significant 
terminal glycan modification that impacts the poten-
tial to inhibit intermolecular and intercellular interac-
tions. Other reports showed that aberrant sialylation 
could promote the invasion and adhesion of cancer cells; 
higher sialic acid content was correlated with cell attach-
ment and migration, thus contributing to the migratory 
and invasive phenotype of the cells. A previous study 
reported that the amount of sialylated glycans on gp96 
was significantly lower in regressing cells than that in 
progressively growing cells. Moreover, the aberrations 
in the sialic acid content of gp96 can affect its essential 
protein–protein interaction with antigen presenting cell 
surface receptors, thus affecting the immunogenicity of 
gp96 [19]. In our study, we found that the sialylation level 
of gp96 varied across different cancer cell lines, which 
might affect the immunological properties of gp96.
In mammals, sialic acids are found at the non-reducing 
terminal residue of oligosaccharides as α-2,3- or α-2,6-
linked to a α-d-galactopyranosyl (Gal), or α-2,6-linked 
to a α-d-N-acetylgalactosaminyl (GalNAc) or a α-d-N-
acetylglucosaminyl (GlcNAc), the patterns commonly 
found in glycoproteins [20]. Sialic acids are also found 
α-2,8-linked to other sialic acids of gangliosides and in 
polysialic acid. The linear homopolymer has also been 
observed on several glycoproteins including the neural 
cell adhesion molecule [21].
Because sialylation is related to glycosyltransferases, 
studies of glycosyltransferases, including the quantifica-
tion of the glycosyltransferases present in cells and deter-
mination of their corresponding activities, are important. 
A large amount of sialyltransferase was found in animal 
cells, which presented in different tissues or cells and 
performed different functions. Because α-2,8-linked 
sialic acid homopolymers were found in gangliosides, 
polysialic acid, and the neural cell adhesion molecule 
[22], we only investigated α-2,3- or α-2,6-linked sialic 
acid homopolymers.
To further investigate the differences in sialylation of 
gp96, the expression of glycosyltransferases related to 
sialylation, including ST3Gal and ST6Gal1, were exam-
ined by western blot. The expression levels of ST3Gal 
and ST6Gal1 in A549 and Hela cells were higher than 
SW1990 cells, which was in agreement with sialylation 
levels and indicated that the higher sialylation may be 
due to the differences in expression levels of sialyltrans-
ferase. Additional studies are currently underway, and 
the specific influence of immunity and tumor cell migra-
tion are under investigation.
Furthermore, variations in sialylation of gp96 in MCF-7 
and SK-BR-3 cell lines were analyzed. The result showed 
that the difference of sialylated levels was agree with the 
metastasis capability.
We speculate that the difference in the sialylation level 
of gp96 from different cancer cell lines might affect cel-
lular behaviors, including proliferation, metastasis, differ-
entiation, and other processes, and necessitates further 
investigation.
Conclusions
In our study, we established a new method for investigat-
ing the expression and sialylation of glycoproteins using 
metabolic labeling, click chemistry, and avidin–biotin 
affinity. We successfully used this method to isolate and 
purify the sialylated glycoproteins present on the cell 
surface of three different cancer cell lines. Our results 
showed that the sialylation level of gp96 varied across 
different cancer cell lines, and this may be due to differ-
ences in sialyltransferase expression in different cell lines. 




Ac4ManNAz was synthesized following the protocol 
described by Srinivasa-Gopalan Sampathkumar [23]. In 
this study, biotin-LC-alkyne analogs were synthesized 
using the modified commercialized reagent sulfo-NHS-
LC-biotin (Pierce Biotechnology, Rockford, IL, USA), 
which underwent reaction with propargylamine in borate 
buffer (0.2 M, pH 8) to modify one end of the long chain 
with an alkyne. HeLa, SW1990, A549 cells MCF-7 and 
SK-BR-3 cells were obtained from ATCC (USA).
Biotinylation of azido‑labeled glycoproteins
HeLa, SW1990, and A549 cells were cultured for 48 h, at 
37  °C and 5  % CO2 in DMEM medium (10  % FBS, 100 
units·mL−1 penicillin, and 100  ng  mL−1 streptomycin) 
supplemented with 0.2  mM Ac4ManNAz. As a control, 
an identical volume of PBS was added to the culture 
medium. Cells were washed three times with ice-cold 
0.1 M PBS (phosphate buffer and 0.15 M NaCl, pH 7.4) 
and then treated with 1 mL of reaction solution (0.2 mM 
biotin-LC-alkyne, 0.2  mM Tris-triazoleamine catalyst, 
1.0 mM CuSO4, and 2.0 mM sodium ascorbate in ice-cold 
PBS). After incubation for 1 h at 4 °C, the cells were fixed 
in 4  % paraformaldehyde for 30  min and then washed 
three times with PBS. Cells were stained using 1  mL of 
a 1:1000 dilution of avidin-Cy3 (Boster, Wuhan, China) 
at room temperature for 30 min. After washing samples 
with PBS carefully, fluorescence images were obtained 
using laser scanning confocal microscopy.
Purification of biotinylated glycoproteins
Cells were cultured in Ac4ManNAz for 48  h as previ-
ously described and treated with biotin-LC-alkyne at 
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4 °C. After incubation for 1 h, the reaction solution was 
removed, and the cells were carefully washed with ice-
cold PBS. The cells were scraped into ice-cold hypotonic 
buffer (10  mM HEPES, pH 7.5, 1.5  mM MgCl2, 10  mM 
KCl, 1× protease inhibitor cocktail, 1  mM NaF, and 
1  mM Na3VO4), incubated on ice for 15  min, and then 
lysed by ultrasonication. After centrifugation at 1000g 
and 4  °C for 10  min, the supernatant was collected. 
Next, KCl was added to a concentration of 150  mM. 
Protein concentrations were quantified and diluted to 
1 mg mL−1. SMMs were added at a volume that was 1/10 
of the volume of the supernatant, and the samples were 
incubated at 4  °C for 1  h. Finally, SMMs were carefully 
and separately washed with ice-cold PBS and 1  M KCl, 
suspended in 1× SDS-PAGE loading buffer, and boiled 
for 10 min, resulting in the purified glycoprotein samples.
Western blot
The purified glycoproteins were separated using SDS-
PAGE and transferred onto a PVDF membrane. Mem-
branes were blocked in 4  % nonfat dry milk for 1  h at 
room temperature (RT). A 1:1000 dilution of HRP-
labeled streptavidin (Boster, Wuhan, China) was added, 
and the membrane was incubated at RT for 1  h. Bioti-
nylated glycoproteins were detected using electrochemi-
luminescence (ECL). To detect gp96 protein expression, 
the membrane was incubated with a 1:1,000 dilution of 
an anti-gp96 antibody (Santa Cruz, Dallas, USA) over-
night at 4 °C followed by incubation with an HRP-labeled 
secondary antibody for 1  h. Sialyltransferase was ana-
lyzed using 1:1,000 dilution of anti-ST3Gal (Santa Cruz) 
and 1:1000 dilution of anti-ST6Gal1 (Immunoway, New-
ark, USA) as primary antibodies. Protein expressions 
were detected using ECL. β-actin served as an internal 
control and a 1:1000 dilution of anti-β-actin antibody was 
used.
HPLC–MS/MS
HPLC–MS/MS and the analysis were performed by 
Shanghai Applied Protein Technology Co., Ltd.
Real‑time PCR
The mRNA of the different cell lines was isolated using 
a PolyATtract System 1000 (Promega, Madison, USA) 
and reverse transcribed to cDNA using a PrimeScript RT 
reagent kit (Takara, Dalian, China). Real-time PCR was 
performed using an SYBR Premix EX Taq II kit (Takara). 
The primers used in this study were as follows: gp96 for-
ward primer, 5′-TGT TTC CCG CGA GAC TCT TC-3′; 
gp96 reverse primer, 5′-CAC ACC AGC ACT GCT GTG 
CAC CAC AGT GG-3′; GAPDH forward primer, 5′-GTG 
AAG GTC GGA GTC AAC G-3′; and GAPDH reverse 
primer, 5′-TGA GGT CAA TGA AGG GGT C-3′.
ELISA
A 96-well plate was coated with a 1:1000 dilution of an 
anti-gp96 antibody at 37  °C for 4  h and subsequently 
blocked with 1  % normal goat serum at 4  °C overnight. 
After careful washing with PBS, purified glycoproteins 
(0.5  mg  mL−1) were added and incubated at 37  °C for 
1  h. After washing with PBS, a 1:1000 dilution of HRP-
streptavidin or a 1:1000 dilution of HRP-WGA (Sigma, 
St. Louis, MO, USA) was added and incubated at RT 
for 1  h. Finally, the signal was visualized using TMB as 
a chromogen. To detect sialyation of gp96 in MCF-7 and 
SK-BR-3 cells, we performed ELISA using HRP-WGA.
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